Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 36.00
Change Today -0.30 / -0.83%
Volume 206.9K
MDGS On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ CM
Tel Aviv
As of 9:24 AM 08/2/15 All times are local (Market data is delayed by at least 15 minutes).

medigus ltd (MDGS) Snapshot

Open
$36.30
Previous Close
$36.30
Day High
$36.30
Day Low
$35.90
52 Week High
04/14/15 - $58.90
52 Week Low
12/30/14 - $25.00
Market Cap
115.4M
Average Volume 10 Days
1.8M
EPS TTM
$-0.11
Shares Outstanding
320.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIGUS LTD (MDGS)

Related News

No related news articles were found.

medigus ltd (MDGS) Related Businessweek News

No Related Businessweek News Found

medigus ltd (MDGS) Details

Medigus Ltd., a medical device company, designs, develops, and sells minimally invasive endosurgical tools and imaging solutions. It offers the MUSE system, a proprietary disposable endoscopic device comprising a micro-camera, a surgical endostapler, and an ultrasound sensor for the treatment of gastroesophageal reflux disease. The company was founded in 1999 and is headquartered in Omer, Israel.

Founded in 1999

medigus ltd (MDGS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 1.9M
Founder
Total Annual Compensation: 1.1M
Chief Financial Officer
Total Annual Compensation: 630.0K
Chief Technology Officer and Vice President o...
Total Annual Compensation: 635.0K
Executive Vice President
Total Annual Compensation: 523.0K
Compensation as of Fiscal Year 2014.

medigus ltd (MDGS) Key Developments

Medigus Ltd. Receives Approval from Israeli Ministry of Health to Market the Muse(TM) System

Medigus Ltd. announced that the company has received approval from the Israeli Ministry of Health (MOH) to market the Medigus Ultrasonic Surgical Endostapler, or MUSE™ system in Israel. The new MOH approval takes effect immediately and will expire in December 2016. The MUSE system is also FDA cleared and CE marked for the treatment of GERD in the United States and Europe, respectively. The new approval of the MOH was granted to Medigus following the expiration in February 2014 of the previously granted approval.

National Aeronautics and Space Administration Uses Medigus Ltd.'s micro ScoutCam 1.2 Camera

Medigus Ltd. announced that the National Aeronautics and Space Administration has successfully used the company micro ScoutCam 1.2, the world's smallest camera, for the first time in space as part of NASA's Visual Inspection Poseable Invertebrate Robot (VIPIR) tool. VIPIR is a robotic, multi-capability inspection tool that is being tested as part of the Robotic Refueling Mission, an experiment on the International Space Station that has been demonstrating tools, technologies and techniques for on-orbit satellite servicing since 2011. Micro ScoutCam 1.2, at a mere 1.2mm diameter in size, is being utilized as the borescope camera on VIPIR. As part of the second phase of NASA's Robotic Refueling Mission, VIPIR, incorporating micro ScoutCam 1.2 at the end of a deployable video borescope, was used in May 2015 to demonstrate various camera inspection capabilities for NASA in space. VIPIR was launched to the International Space Station in July 2014 on board the European Space Agency's Automated Transfer Vehicle 5. Micro ScoutCam 1.2's versatility is supported by key features including its miniature size, remarkable image quality, customizable optics, waterproof materials, and its adaptability in extreme temperatures. It can be tailored for both medical and industrial applications.

Medigus Ltd. Appoints Gilad Mamlok as Chief Financial Officer Effective August 1, 2015

Medigus Ltd. announced that it has appointed Gilad Mamlok as Chief Financial Officer effective August 1, 2015. Mr. Mamlok brings over two decades of financial management and business development experience to his new role at Medigus. Most recently, Mr. Mamlok served as Vice President of Finance at Covidien plc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDGS:IT 36.00 -0.30

MDGS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDGS.
View Industry Companies
 

Industry Analysis

MDGS

Industry Average

Valuation MDGS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIGUS LTD, please visit www.medigus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.